Singapore, April 3 -- Thermo Fisher Scientific Inc. has announced the global launch of the Gibco™ CTS™ Compleo™ Fill and Finish System, an automated, functionally closed solution designed to streamline formulation and filling in cell therapy manufacturing.

Because cell therapies often begin with patient-derived cells, manufacturing workflows must accommodate variability in cell count, concentration and viability. As more therapies move toward commercialization, manufacturers are seeking to reduce manual intervention and improve operational efficiency while maintaining strict requirements for sterility, dose accuracy and product consistency.

Formulation and filling have been traditionally performed using manual met...